RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: prostatic hypertrophy
Accession: DOID:11132
browse the term
Definition: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Synonyms: exact_synonym: benign prostatic hyperplasia; benign prostatic hypertrophy; prostatic hyperplasia
primary_id: MESH:D011470
alt_id: MIM:600082
xref: EFO:0000284 ; NCI:C2897
For additional species annotation, visit the
Alliance of Genome Resources .
G
Ar
androgen receptor
treatment
IMP
RGD
PMID:22430536 PMID:24872436
RGD:10043335 , RGD:10045676
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Atf4
activating transcription factor 4
ISO
RGD
PMID:28988820
RGD:13504679
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Bad
BCL2-associated agonist of cell death
ISO
protein:increased expression:prostate gland
RGD
PMID:11781193
RGD:2292676
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Casp1
caspase 1
ISO
protein:decreased expression:prostate gland
RGD
PMID:16333955
RGD:2315883
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
G
Casp6
caspase 6
ISO
RGD
PMID:15507514
RGD:2301337
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Ccnb1
cyclin B1
ISO
RGD
PMID:12670908
RGD:2315046
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Cdk4
cyclin-dependent kinase 4
IEP
protein:decreased expression:prostate gland
RGD
PMID:17962342
RGD:2289135
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
Cftr
CF transmembrane conductance regulator
ISO
protein:decreased expression:prostate gland
RGD
PMID:25546515
RGD:11566048
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:46,560,885...46,728,756
G
Clu
clusterin
IEP
mRNA, protein:increased expression:prostate gland
RGD
PMID:19443575
RGD:9068410
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Esr1
estrogen receptor 1
treatment
IMP
RGD
PMID:24872436
RGD:10045676
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
treatment
ISO
RGD
PMID:17068134
RGD:8552985
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Fadd
Fas associated via death domain
treatment
IDA
RGD
PMID:27441629
RGD:13792501
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Fgf7
fibroblast growth factor 7
no_association
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14999240 PMID:9285567 PMID:11482780 PMID:9000125
RGD:2289086 , RGD:2289085 , RGD:2301094
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:113,281,283...113,332,929
G
Fgf8
fibroblast growth factor 8
ISO
RGD
PMID:10343609
RGD:2289343
NCBI chr 1:254,533,504...254,539,605
Ensembl chr 1:244,584,652...244,590,359
G
Ghrh
growth hormone releasing hormone
treatment
IMP
RGD
PMID:22341819 PMID:21321192
RGD:10401238 , RGD:10401264
NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889
G
Gnrh1
gonadotropin releasing hormone 1
treatment
IMP
RGD
PMID:22341819
RGD:10401238
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
G
Gstp1
glutathione S-transferase pi 1
treatment
IEP
RGD
PMID:24205794
RGD:10401934
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Igf1r
insulin-like growth factor 1 receptor
ISO
mRNA: increased expression: prostate
RGD
PMID:9215294
RGD:7242915
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Il13
interleukin 13
IEP
mRNA:increased expression:prostate gland
RGD
PMID:20945403
RGD:5684375
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il3
interleukin 3
IEP
mRNA: increased expression: prostate
RGD
PMID:20945403
RGD:5684375
NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,405,716...38,408,066
G
Il5
interleukin 5
treatment
IEP
RGD
PMID:20945403
RGD:5684375
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213
G
Kdr
kinase insert domain receptor
IEP
RGD
PMID:15999482
RGD:2292079
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Klk1c10
kallikrein 1-related peptidase C10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21128595
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:94,402,993...94,407,052
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
IDA
RGD
PMID:22684563
RGD:7240520
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
ISO
RGD
PMID:7693635
RGD:2299076
NCBI chr10:79,394,999...79,400,418
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
G
Pdgfb
platelet derived growth factor subunit B
ISO
RGD
PMID:22689130
RGD:13506770
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfd
platelet derived growth factor D
disease_progression
ISO
RGD
PMID:22689130
RGD:13506770
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2208075
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Pten
phosphatase and tensin homolog
ISO
RGD
PMID:11175795
RGD:1302553
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:prostate gland
RGD
PMID:25546515
RGD:11566048
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:prostate gland
RGD
PMID:25546515
RGD:11566048
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Srd5a1
steroid 5 alpha-reductase 1
severity
ISO
DNA:SNPs:cds
RGD
PMID:15136785
RGD:2302559
NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:33,686,391...33,720,461
G
Srd5a2
steroid 5 alpha-reductase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20823678
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
G
Tmprss2
transmembrane serine protease 2
ISO
protein:increased expression:prostate gland
RGD
PMID:18338334
RGD:2324904
NCBI chr11:36,934,306...36,973,779
Ensembl chr11:36,934,306...36,973,715
G
Tp73
tumor protein p73
ISO
mRNA:alternative forms
RGD
PMID:15492805
RGD:2298529
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:164,621,377...164,681,128
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all